Insiders | Shares | % | Avg Price | Total $ | |
---|---|---|---|---|---|
Buys | 0 | ||||
Sells | 10 | -20.6M | 100% | $203.90 | -$4.2B |
Net | -10 | -20.6M | -100% | -$4.2B |
Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
Hhlr Advisors, Ltd. | 10%+ Owner | $25B | -$3.57B | -12.5% | Dec 2, 2024 |
Amgen Inc | 10%+ Owner | $3.42B | Sep 10, 2021 | ||
John Oyler | Chief Executive Officer, Director | $2.25B | -$83M | -3.56% | Sep 16, 2025 |
Baker Bros. Advisors Lp | Director | $2.14B | -$385M | -15.3% | May 21, 2025 |
Xiaodong Wang | Director, Chair, Scientific Advisory Brd | $1.2B | -$77.8M | -6.07% | Sep 9, 2025 |
Donald W. Glazer | Director | $565M | Jun 5, 2024 | ||
Lai Wang | Global Head of R&D | $394M | -$5.6M | -1.4% | Sep 9, 2025 |
Xiaobin Wu | President and COO | $367M | -$69.4M | -15.9% | Aug 13, 2025 |
Howard Liang | CFO & Chief Strategy Officer | $323M | Jun 28, 2021 | ||
Julia Aijun Wang | Chief Financial Officer | $88.6M | Jul 1, 2024 | ||
Chan Henry Lee | SVP, General Counsel | $75.1M | -$7.78M | -9.39% | Sep 10, 2025 |
Aaron Rosenberg | Chief Financial Officer | $50.2M | -$346K | -0.68% | Aug 1, 2025 |
Jane Huang | CMO, Hematology | $33.2M | Dec 14, 2021 | ||
Titus B. Ball | Principal Accounting Officer | $21.6M | -$74.5K | -0.34% | Sep 2, 2025 |
(Corsee) Sanders Corazon | Director | $17.1M | -$898K | -5% | Sep 5, 2025 |
Anthony C. Hooper | Director | $15.9M | May 21, 2025 | ||
Thomas Malley | Director | $15.1M | Jun 15, 2023 | ||
Margaret Dugan | Director | $13.9M | May 21, 2025 | ||
Alessandro Riva | Director | $13.9M | May 21, 2025 | ||
Olivier Brandicourt | Director | $6.69M | May 21, 2025 | ||
Qingqing Yi | Director | $6.37M | Jun 10, 2025 | ||
Shalini Sharp | Director | $4.69M | May 21, 2025 | ||
Jingshyh S. su | Director | $1.62M | Jun 16, 2021 | ||
Timothy Yung-Cheng Chen | Director | $1.62M | Jun 16, 2021 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|